Actively Recruiting

Age: 18Years +
MALE
NCT06380738

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Led by AstraZeneca · Updated on 2025-12-26

250

Participants Needed

34

Research Sites

154 weeks

Total Duration

On this page

Sponsors

A

AstraZeneca

Lead Sponsor

M

Merck Sharp & Dohme LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

PROceed is a multisite, prospective, observational study that describes the real-world use and clinical experience of mCRPC patients treated with the combination of olaparib and abiraterone in the mCRPC setting. Clinical outcomes will be assessed in patients who are either NHA-naive or NHA-exposed prior to initiating olaparib + abiraterone treatment, respectively. Patient demographic and clinical characteristics, as well as treatment received prior and subsequent to olaparib + abiraterone, will also be described. The study plans to enroll patients for a maximum of 2 years and follow up patients from initiation of olaparib until 1 year post last patient in.

CONDITIONS

Official Title

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to provide written informed consent
  • 18 years of age and above
  • Documented histopathology or cytopathology of prostate cancer, adenocarcinoma
  • Confirmed metastatic castration-resistant prostate cancer
  • Initiated olaparib plus abiraterone treatment after site activation
Not Eligible

You will not qualify if you...

  • Participation in a clinical trial with an investigational prostate cancer treatment within 30 days prior to starting olaparib

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 34 locations

1

Research Site

Aschaffenburg, Germany

Actively Recruiting

2

Research Site

Augsburg, Germany

Actively Recruiting

3

Research Site

Bergisch Gladbach, Germany

Actively Recruiting

4

Research Site

Berlin, Germany

Actively Recruiting

5

Research Site

Bonn, Germany

Actively Recruiting

6

Research Site

Cologne, Germany

Actively Recruiting

7

Research Site

Dresden, Germany

Actively Recruiting

8

Research Site

Duisburg, Germany

Actively Recruiting

9

Research Site

Eisenach, Germany

Actively Recruiting

10

Research Site

Eisleben Lutherstadt, Germany

Actively Recruiting

11

Research Site

Frankfurt, Germany

Actively Recruiting

12

Research Site

Greifswald, Germany

Actively Recruiting

13

Research Site

Halle, Germany

Actively Recruiting

14

Research Site

Hamburg, Germany

Actively Recruiting

15

Research Site

Hanover, Germany

Actively Recruiting

16

Research Site

Heidelberg, Germany

Actively Recruiting

17

Research Site

Heinsberg, Germany

Actively Recruiting

18

Research Site

Herzogenaurach, Germany

Actively Recruiting

19

Research Site

Leipzig, Germany

Actively Recruiting

20

Research Site

Lübeck, Germany

Actively Recruiting

21

Research Site

Lüneburg, Germany

Actively Recruiting

22

Research Site

Magdeburg, Germany

Actively Recruiting

23

Research Site

Marburg, Germany

Actively Recruiting

24

Research Site

Mülheim, Germany

Actively Recruiting

25

Research Site

Münster, Germany

Actively Recruiting

26

Research Site

Neunkirchen, Germany

Actively Recruiting

27

Research Site

Nuremberg, Germany

Actively Recruiting

28

Research Site

Rüsselsheim am Main, Germany

Actively Recruiting

29

Research Site

Saalfeld, Germany

Actively Recruiting

30

Research Site

Speyer, Germany

Actively Recruiting

31

Research Site

Trier, Germany

Actively Recruiting

32

Research Site

Tübingen, Germany

Actively Recruiting

33

Research Site

Westerstede, Germany

Actively Recruiting

34

Research Site

Wetzlar, Germany

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) | DecenTrialz